Related Experiment Videos
Pretransfusion trigger platelet counts and dose for prophylactic platelet transfusions.
1Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242-1009, USA. ronald-strauss@uiowa.edu
Current Opinion in Hematology
|October 12, 2005
Summary
Current guidelines for platelet transfusion triggers in marrow failure patients lack definitive evidence. Platelet transfusion doses should aim for specific blood platelet counts based on patient stability and bleeding risk.
Area of Science:
- Hematology
- Transfusion Medicine
- Clinical Practice Guidelines
Background:
- Thrombocytopenia due to marrow failure necessitates careful management of platelet transfusions.
- Optimal platelet transfusion triggers and doses remain debated due to limited high-quality evidence.
Purpose of the Study:
- To critically evaluate current blood platelet count thresholds for initiating platelet transfusions.
- To assess the optimal dose of platelets for effective hemostasis, feasibility, and safety in patients with thrombocytopenia.
Main Methods:
- Review of existing literature, including retrospective reviews and anecdotal reports, due to the absence of definitive studies.
- Analysis of observational data to inform clinical decision-making.
Main Results:
- No well-designed, prospective, randomized clinical trials currently exist to support evidence-based platelet transfusion decisions.
- Clinical practices are largely based on observational data and expert consensus.
Conclusions:
- In the absence of definitive data, maintain blood platelet counts above 10 x 10^9/L for stable, nonbleeding patients.
- Target blood platelet counts >20 x 10^9/L for unstable nonbleeding patients and >50 x 10^9/L for bleeding patients or those undergoing invasive procedures.